[The Prognostic Value of Lower Pretreatment Advanced Lung Cancer Inflammation Index (ALI) in B Cell Lymphoma]

Overview

Journal Zhonghua Xue Ye Xue Za Zhi

Specialty Hematology

Date 2018 Mar 19

PMID 29551035

Citations 2

Authors

B L Hu

L H Chen

J Q Xu

Z Z Wang

Y W Yu

Y X Han

J Huang

W Y Shen

Affiliations

Soon will be listed here.

Citing Articles

Associations of advanced lung cancer inflammation index with all-cause and respiratory disease mortality in adults with asthma: NHANES, 1999-2018.

Fu J, Zou Y, Luo L, Zhang J, Wang X, Zhang D Sci Rep. 2024; 14(1):29693.

PMID: 39613823 PMC: 11607339. DOI: 10.1038/s41598-024-80983-1.

The advanced lung cancer inflammation index is a prognostic factor for gastrointestinal cancer patients undergoing surgery: a systematic review and meta-analysis.

Liu X, Wang L, Zhang B, Liu X, Li Z, Kang B World J Surg Oncol. 2023; 21(1):81.

PMID: 36879283 PMC: 9987069. DOI: 10.1186/s12957-023-02972-4.

References

Jia W, Wu J, Jia H, Yang Y, Zhang X, Chen K . The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients. PLoS One. 2015; 10(11):e0143061. PMC: 4666347. DOI: 10.1371/journal.pone.0143061. View

Breccia M, Mazzarella L, Bagnardi V, Disalvatore D, Loglisci G, Cimino G . Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols. Blood. 2011; 119(1):49-54. DOI: 10.1182/blood-2011-07-369595. View

Park Y, Yi H, Lee M, Kim C, Lim J . Prognostic Value of the Pretreatment Advanced Lung Cancer Inflammation Index (ALI) in Diffuse Large B Cell Lymphoma Patients Treated with R-CHOP Chemotherapy. Acta Haematol. 2017; 137(2):76-85. DOI: 10.1159/000452991. View

Xie X, Luo K, Hu Y, Wang J, Chen J . Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer. Dis Esophagus. 2014; 29(1):79-85. DOI: 10.1111/dote.12296. View

Koh Y, Kang H, Park C, Yoon D, Kim S, Suh C . Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma. Am J Clin Pathol. 2012; 138(6):846-54. DOI: 10.1309/AJCPO46GFKGNXCBR. View

Huang J, Jiang W, Lin T, Huang Y, Xu R, Huang H . Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type. Ann Oncol. 2010; 22(1):149-155. DOI: 10.1093/annonc/mdq314. View

Rieger M, Osterborg A, Pettengell R, White D, Gill D, Walewski J . Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study. Ann Oncol. 2010; 22(3):664-670. DOI: 10.1093/annonc/mdq418. View

Zhou D, Zhang Y, Xu L, Zhou Z, Huang J, Chen M . A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma. Sci Rep. 2015; 5:15263. PMC: 4614102. DOI: 10.1038/srep15263. View

Partridge M, Fallon M, Bray C, McMillan D, Brown D, Laird B . Prognostication in advanced cancer: a study examining an inflammation-based score. J Pain Symptom Manage. 2012; 44(2):161-7. DOI: 10.1016/j.jpainsymman.2011.08.013. View

10.

Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K . Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer. Anticancer Res. 2016; 36(3):995-1001. View

11.

Cheson B, Pfistner B, Juweid M, Gascoyne R, Specht L, Horning S . Revised response criteria for malignant lymphoma. J Clin Oncol. 2007; 25(5):579-86. DOI: 10.1200/JCO.2006.09.2403. View

12.

Cengiz F, Emiroglu N, Ozkaya D, Bahali A, Su O, Onsun N . Prognostic Evaluation of Neutrophil/Lymphocyte Ratio in Patients with Mycosis Fungoides. Ann Clin Lab Sci. 2017; 47(1):25-28. View

13.

Arigami T, Uenosono Y, Ishigami S, Okubo K, Kijima T, Yanagita S . A Novel Scoring System Based on Fibrinogen and the Neutrophil-Lymphocyte Ratio as a Predictor of Chemotherapy Response and Prognosis in Patients with Advanced Gastric Cancer. Oncology. 2016; 90(4):186-92. DOI: 10.1159/000444494. View

14.

He X, Zhou T, Yang Y, Hong S, Zhan J, Hu Z . Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer. Clin Lung Cancer. 2015; 16(6):e165-71. DOI: 10.1016/j.cllc.2015.03.005. View

15.

Ohno Y, Nakashima J, Nakagami Y, Satake N, Gondo T, Ohori M . Sex and the clinical value of body mass index in patients with clear cell renal cell carcinoma. Br J Cancer. 2013; 109(7):1899-903. PMC: 3790167. DOI: 10.1038/bjc.2013.512. View

16.

Jafri S, Shi R, Mills G . Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer. 2013; 13:158. PMC: 3618002. DOI: 10.1186/1471-2407-13-158. View

17.

Gupta D, Lis C . Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010; 9:69. PMC: 3019132. DOI: 10.1186/1475-2891-9-69. View

18.

Templeton A, Knox J, Lin X, Simantov R, Xie W, Lawrence N . Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy. Eur Urol. 2016; 70(2):358-64. DOI: 10.1016/j.eururo.2016.02.033. View

19.

Yumuk P, Dane F, Yumuk V, Yazici D, Ege B, Bekiroglu N . Impact of body mass index on cancer development. J BUON. 2008; 13(1):55-9. View